About AVVISTO THERAPEUTICS LLC
Avvisto Therapeutics is a biopharmaceutical company focused on the development and commercialization of Cycloset, an FDA-approved medication for the treatment of Type 2 Diabetes.
Development of FDA-approved pharmaceutical productsConducting pre-clinical and clinical studiesPeer-reviewed publication of research findings
Is this your company?
Claim AVVISTO THERAPEUTICS LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim AVVISTO THERAPEUTICS LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.